Paul Mathew, MD | Authors

The Hemostatic System as a Therapeutic Target in Urothelial Carcinoma

October 15, 2014

Bladder neoplasms are associated with a high frequency of painless hematuria; however, when compared with the bleeding tendencies of other solid tumors, it is arguable that this comparatively high bleeding frequency is in part the result of an ascertainment bias.

The Bifunctional Role of Steroid Hormones: Implications for Therapy in Prostate Cancer

May 15, 2014

This review examines the relevance of a translational framework for studying therapeutic androgens in prostate cancer.

Bladder Cancer: Imperatives for Personalized Medicine

September 15, 2011

Wide variations in the care of early bladder cancer exist, and among high–treatment intensity urology providers, overall survival is unchanged while rates of transition to major surgery are actually increasing. It has been said that for bladder tumors, it is time for a paradigm shift. We believe that the time is overdue.